A study on the prevention of thrombosis after simultaneous pancreas-kidney transplantation
Technology and Health Care · 2024
DOI: 10.3233/thc-232037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology and Health Care, 2024. Verfasst von Jin-Peng Tu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplant Department, Tianjin First Central Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Kidney Transplantation, Pancreas Transplantation, Thrombosis, Anticoagulants. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Renal failure is one of the most common chronic complications of diabetes. Simultaneous pancreas-kidney transplantation (SPK) is considered the preferred treatment for individuals with diabetes and chronic renal failure. This procedure has demonstrated efficacy in enhancing the quality of life for patients and minimizing the complications associated with diabetes. OBJECTIVE: In this study, we analyzed the incidence and safety of complications in different thrombosis prevention techniques post simultaneous pancreas-kidney transplantation (SPK). METHODS: Patients who underwent SPK between January 2019 and December 2022 were selectively categorized into two groups: the heparin group and the non-heparin group depending on the utilization of low molecular weight heparin. The occurrence of complications and clinical outcomes were subsequently calculated in each group. RESULTS: In this study, we included a total of 58 recipients who underwent SPK, with 36 in the heparin group and 22 in the non-heparin group. Among the 58 participants, there were 3 cases of pancreatic thrombosis complications, with 2 cases (5.6%) in the heparin group and 1 case (4.6%) in the non-heparin group, and the differences were not statistically significant (P> 0.05). Regarding gastrointestinal bleeding, there were 17 cases out of the total 58 patients, with 14 cases (38.9%) in the heparin group and 3 cases (13.6%) in the non-heparin group, and the difference was statistically significant (P< 0.05). CONCLUSION: After surgery, the use of low molecular weight heparin anticoagulation may increase the likelihood of experiencing gastrointestinal bleeding. Prior to the surgery, a comprehensive evaluation of the coagulation status and medical history of the patient should be performed, enabling stratification of risks involved. Based on this assessment, either low-molecular-weight heparin or aspirin should be selected as a preventive measure against thrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organ Transplant Department, Tianjin First Central Hospital, Tianjin, China.
- Organ Transplant Department, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zitieren
APA
Tu, J. P., Shi, X. F., Wang, H., Zhao, J., Wang, X., Mo, C. B., & Song, W. L. (2024). A study on the prevention of thrombosis after simultaneous pancreas-kidney transplantation. Technology and Health Care. https://doi.org/10.3233/thc-232037
Vancouver
Tu JP, Shi XF, Wang H, Zhao J, Wang X, Mo CB, et al. A study on the prevention of thrombosis after simultaneous pancreas-kidney transplantation. Technology and Health Care. 2024. doi:10.3233/thc-232037
BibTeX
@article{Tu2024,
author = {Tu, Jin-Peng and Shi, Xiao-Feng and Wang, Hui and Zhao, Jie and Wang, Xin and Mo, Chun-Bai and Song, Wen-Li},
title = {A study on the prevention of thrombosis after simultaneous pancreas-kidney transplantation},
journal = {Technology and Health Care},
year = {2024},
doi = {10.3233/thc-232037}
}
EUVIMED